Effect of chronic L-dopa or melatonin treatments after dopamine deafferentation in rats: dyskinesia, motor performance, and cytological analysis.
about
Melatoninergic System in Parkinson's Disease: From Neuroprotection to the Management of Motor and Nonmotor SymptomsMelatonin for Sleep Disorders in Patients with Neurodegenerative Diseases.Rapid Eye Movement Sleep Homeostatic Response: A Potential Marker for Early Detection of Parkinson's Disease.Effects of Melatonin Levels on Neurotoxicity of the Medial Prefrontal Cortex in a Rat Model of Parkinson's Disease.Melatonin enhances L-DOPA therapeutic effects, helps to reduce its dose, and protects dopaminergic neurons in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice.
P2860
Effect of chronic L-dopa or melatonin treatments after dopamine deafferentation in rats: dyskinesia, motor performance, and cytological analysis.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Effect of chronic L-dopa or me ...... nce, and cytological analysis.
@en
Effect of chronic L-dopa or me ...... nce, and cytological analysis.
@nl
type
label
Effect of chronic L-dopa or me ...... nce, and cytological analysis.
@en
Effect of chronic L-dopa or me ...... nce, and cytological analysis.
@nl
prefLabel
Effect of chronic L-dopa or me ...... nce, and cytological analysis.
@en
Effect of chronic L-dopa or me ...... nce, and cytological analysis.
@nl
P2093
P2860
P356
P1433
P1476
Effect of chronic L-dopa or me ...... ance, and cytological analysis
@en
P2093
Ana Luisa Gutierrez-Valdez
Carmen Torres-Esquivel
Enrique Montiel-Flores
Javier Sánchez-Betancourt
José Luis Ordoñez-Librado
Montserrat Moreno-Rivera
Ricardo García-Ruiz
Verónica Anaya-Martínez
P2860
P304
P356
10.5402/2012/360379
P577
2012-02-01T00:00:00Z